Clinical Trial Update: Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating safety and tolerability of adjunctive TBO-309 during reperfusion for acute ischemic stroke; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• TBO-309

Snippet

Sponsor: The Florey Institute of Neuroscience and Mental Health | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING